Home > Insider Trading > Filing (0001179110-21-002190)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1428336	Healthequity Inc.	HQY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1179972	G Darcy Mott	C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020	Executive Vp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-22	10,000	$14.00	69,884	No	4	M	Direct
Common Stock	Disposition	2021-02-22	3,400	$78.00	66,484	No	4	S	Direct
Common Stock	Disposition	2021-02-22	2,600	$78.88	63,884	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-02-22	10,000	$0.00	10,000	$14.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
90,000		2024-07-30	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$25.39	2025-03-26	25,000	25,000	Direct
Common Stock	Stock Option (right to buy)	$41.28	2027-03-27	19,897	19,897	Direct
Common Stock	Stock Option (right to buy)	$61.72	2028-03-27	14,228	14,228	Direct
Common Stock	Stock Option (right to buy)	$73.61	2029-03-26	15,337	15,337	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-03-26	25,000	25,000	Direct
2027-03-27	19,897	19,897	Direct
2028-03-27	14,228	14,228	Direct
2029-03-26	15,337	15,337	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. The shares reported on this Form 4 are subject to a lock-up agreement between the reporting person and BofA Securities, Inc. dated February 16, 2021 (the "Lock-up Date") pursuant to which the remaining shares reported in Table I of this Form 4 cannot be sold for 45 days following the Lock-up Date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.57 to $78.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.60 to $79.10, inclusive.
The option is immediately exercisable.
The option is exercisable as to 14,922 shares. The option vests as to 4,975 shares on March 27, 2021.
The option is exercisable as to 7,114 shares. The remaining options vest in two equal installments of 3,557 shares on March 27, 2021, and 2022.
The option is exercisable as to 3,835 shares. The remaining options vest as to 3,834 shares on each of March 27, 2021, 2022 and 2023.